These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18288095)

  • 61. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA; Joppa M; Ling N; Foster AC
    J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Footshock-induced urinary bladder hypersensitivity: role of spinal corticotropin-releasing factor receptors.
    Robbins MT; Ness TJ
    J Pain; 2008 Nov; 9(11):991-8. PubMed ID: 18632307
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.
    Kash TL; Winder DG
    Neuropharmacology; 2006 Oct; 51(5):1013-22. PubMed ID: 16904135
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
    Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
    Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tonic modulation of anxiety-like behavior by corticotropin-releasing factor (CRF) type 1 receptor (CRF1) within the medial prefrontal cortex (mPFC) in male mice: role of protein kinase A (PKA).
    Miguel TT; Gomes KS; Nunes-de-Souza RL
    Horm Behav; 2014 Jul; 66(2):247-56. PubMed ID: 24848364
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CRF antagonism within the ventral tegmental area but not the extended amygdala attenuates the anxiogenic effects of cocaine in rats.
    Ettenberg A; Cotten SW; Brito MA; Klein AK; Ohana TA; Margolin B; Wei A; Wenzel JM
    Pharmacol Biochem Behav; 2015 Nov; 138():148-55. PubMed ID: 26441142
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Control of cardiovascular responses to stress by CRF in the bed nucleus of stria terminalis is mediated by local NMDA/nNOS/sGC/PKG signaling.
    Oliveira LA; Gomes-de-Souza L; Benini R; Crestani CC
    Psychoneuroendocrinology; 2018 Mar; 89():168-176. PubMed ID: 29414029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential effects of the CRF-R1 antagonist GSK876008 on fear-potentiated, light- and CRF-enhanced startle suggest preferential involvement in sustained vs phasic threat responses.
    Walker D; Yang Y; Ratti E; Corsi M; Trist D; Davis M
    Neuropsychopharmacology; 2009 May; 34(6):1533-42. PubMed ID: 19078950
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effects of corticotropin-releasing factor and the urocortins on hypothalamic gamma-amino butyric acid release--the impacts on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z; Csabafi K; Jászberényi M; Telegdy G
    Neurochem Int; 2012 Mar; 60(4):350-4. PubMed ID: 22306347
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Posttraining infusion of norepinephrine and corticotropin releasing factor into the bed nucleus of the stria terminalis enhanced retention in an inhibitory avoidance task.
    Liang KC; Chen HC; Chen DY
    Chin J Physiol; 2001 Mar; 44(1):33-43. PubMed ID: 11403518
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats.
    Erb S; Salmaso N; Rodaros D; Stewart J
    Psychopharmacology (Berl); 2001 Dec; 158(4):360-5. PubMed ID: 11797056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Effects of Prior Stress on Anxiety-Like Responding to Intra-BNST Pituitary Adenylate Cyclase Activating Polypeptide in Male and Female Rats.
    King SB; Lezak KR; O'Reilly M; Toufexis DJ; Falls WA; Braas K; May V; Hammack SE
    Neuropsychopharmacology; 2017 Jul; 42(8):1679-1687. PubMed ID: 28106040
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.
    Larson AA; Nunez MG; Kissel CL; Kovács KJ
    Eur J Neurosci; 2015 Nov; 42(10):2772-82. PubMed ID: 26332847
    [TBL] [Abstract][Full Text] [Related]  

  • 75. BNST GluN2D-Containing NMDA Receptors Influence Anxiety- and Depressive-like Behaviors and ModulateCell-Specific Excitatory/Inhibitory Synaptic Balance.
    Salimando GJ; Hyun M; Boyt KM; Winder DG
    J Neurosci; 2020 May; 40(20):3949-3968. PubMed ID: 32277042
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption.
    Ryabinin AE; Yoneyama N; Tanchuck MA; Mark GP; Finn DA
    Neuroscience; 2008 Feb; 151(3):780-90. PubMed ID: 18164138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effect of lateral septum corticotropin-releasing factor receptor 2 activation on anxiety is modulated by stress.
    Henry B; Vale W; Markou A
    J Neurosci; 2006 Sep; 26(36):9142-52. PubMed ID: 16957071
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
    Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses.
    Walker DL; Miles LA; Davis M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1291-308. PubMed ID: 19595731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.